Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.42 - $0.72 $135,721 - $232,665
323,146 Added 20.42%
1,906,002 $1.2 Million
Q3 2023

Nov 14, 2023

BUY
$0.6 - $1.53 $327,191 - $834,338
545,319 Added 52.56%
1,582,856 $949,000
Q2 2023

Aug 11, 2023

BUY
$1.05 - $1.63 $113,659 - $176,442
108,247 Added 11.65%
1,037,537 $1.17 Million
Q1 2023

May 16, 2023

SELL
$1.2 - $2.73 $34,821 - $79,219
-29,018 Reduced 3.03%
929,290 $1.25 Million
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $104,677 - $220,986
61,215 Added 6.82%
958,308 $1.78 Million
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $1.23 Million - $5.57 Million
645,597 Added 256.7%
897,093 $2.21 Million
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $245,237 - $1.04 Million
-115,135 Reduced 31.4%
251,496 $614,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $2.46 Million - $6.1 Million
-391,093 Reduced 51.61%
366,631 $2.92 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $4.45 Million - $8.69 Million
302,940 Added 66.61%
757,724 $11.6 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $1.1 Million - $1.52 Million
45,299 Added 11.06%
454,784 $12.9 Million
Q2 2021

Aug 11, 2021

SELL
$26.09 - $40.4 $15.7 Million - $24.3 Million
-602,020 Reduced 59.52%
409,485 $13.8 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $1.66 Million - $2.86 Million
50,223 Added 5.22%
1,011,505 $38.7 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $14.5 Million - $21.3 Million
370,765 Added 62.79%
961,282 $40.2 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $22.2 Million - $34.9 Million
-780,618 Reduced 56.93%
590,517 $25.6 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $8.59 Million - $22.2 Million
733,303 Added 114.97%
1,371,135 $41.5 Million
Q1 2020

May 15, 2020

BUY
$7.64 - $27.5 $1.48 Million - $5.32 Million
193,562 Added 43.57%
637,832 $8.72 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $1.1 Million - $1.51 Million
-73,340 Reduced 14.17%
444,270 $7.17 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $3.11 Million - $4.54 Million
164,955 Added 46.78%
517,610 $9.97 Million
Q2 2019

Aug 16, 2019

BUY
$17.37 - $26.27 $1.03 Million - $1.56 Million
59,253 Added 20.2%
352,655 $8.29 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $4.02 Million - $6.08 Million
231,255 Added 372.11%
293,402 $6.9 Million
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $745,911 - $1.32 Million
-80,552 Reduced 56.45%
62,147 $687,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $540,014 - $1.31 Million
71,620 Added 100.76%
142,699 $2.39 Million
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $631,892 - $739,221
71,079
71,079 $666,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.